Log in

Relevant bibliographies by topics / Cardiac / Journal articles

To see the other types of publications on this topic, follow the link: Cardiac.

Journal articles on the topic 'Cardiac'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cardiac.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Rodríguez, Javier, Signed Prieto, Milena Flórez, Claudia Alarcón, Ruth López, Gydnea Aguirre, Laura Pinilla, Omar Rovira, and Laura Méndez. "Cardiac dynamic systems in normal neonates: Neonate chaotic cardiac law." Salud Uninorte 30, no. 3 (December 15, 2014): 361–70. http://dx.doi.org/10.14482/sun.30.3.5757.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Debbal, Sidi. "Cardiac Severity Analysis." Journal of Thoracic Disease and Cardiothoracic Surgery 2, no. 2 (August 11, 2021): 01–09. http://dx.doi.org/10.31579/2693-2156/023.

Full text

Abstract:

Phonocardiogram (PCG) signal is a particular approach to explore cardiac activity, to develop technics that may serve medical staff to diagnose several cardiac diseases. We took advantage of PCG signal that shows heart murmurs on its tracing dissimilar to other cardiac signals, to design an algorithm to study and classify heart murmurs. In this paper, the importance is given to the severity of murmurs to highlight its impact, since depending on its stage the patient could be in life-threatening point; therefore, the purpose of this paper is focused on three essential steps: according to the algorithm, extracting murmurs and classifying them to deferent stages then investigate the impact of severity on cardiac frequency through some parameters. The severity stage calculation was based on energy ratio (ER) which is recommended by recent studies as an effective factor, however, we succeed to validate that murmur energy (ME) is also a qualified feature to determine severity. But despite that murmur duration, it's an inefficient way to judge the cardiac severity, which is a very important indicator of the general health of the human body. This study is done on considering many patients and it reveals very interesting results.

APA, Harvard, Vancouver, ISO, and other styles

3

Hashmi, Faiz, and Nikita Sharma. "Cardiac Nuclear Medicine." International Journal of Trend in Scientific Research and Development Volume-2, Issue-1 (December 31, 2017): 1235–42. http://dx.doi.org/10.31142/ijtsrd8212.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kisan, Chopade Dnyandeo, Parate Swapna, Gangane Suresh, and Chopade Sandesh. "Cytogenetic Association of Cardiac and Non-Cardiac Anomalies in Down’s Syndrome." Indian Journal of Genetics and Molecular Research 7, no. 1 (2018): 5–11. http://dx.doi.org/10.21088/ijgmr.2319.4782.7118.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Eun, Sung-Jong, and Jin-Sun Kook. "Evaluation of Cardiac Ejection Fraction using Cardiac MRI." Journal of the Korean Society of Radiology 5, no. 5 (October 31, 2011): 289–94. http://dx.doi.org/10.7742/jksr.2011.5.5.289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jacome Ruiz, Pablo, and Christian Baquerizo Cardenas. "Monitor Cardíaco Portátil con Interfaz Bluetooth “CARDIO UEES” / Portable Heart Monitor with a Bluetooth Interface “CARDIO UEES”." Ciencia Unemi 9, no. 20 (December 20, 2016): 36. http://dx.doi.org/10.29076/issn.2528-7737vol9iss20.2016pp36-49p.

Full text

Abstract:

En este trabajo se presenta el desarrollo e implementación de un monitor cardiaco capaz de cumplir con características de portabilidad, facilidad de uso y tiempo prolongado de operación. El diseño se divide en dos fases. En la primera, cada etapa del monitor cardiaco se implementa priorizando su consumo individual de energía. En la segunda fase, se integran las etapas para conformar el monitor cardiaco, constituido por una fuente de alimentación, una interfaz con el paciente, un micro controlador, una interfaz inalámbrica y una aplicación que se ejecuta en un teléfono inteligente. Para cumplir con las dos fases de diseño se exponen inicialmente los fundamentos teóricos y el desarrollo actual de la monitorización cardiaca. Posteriormente, para cada etapa se describen los requerimientos funcionales y las variables relevantes para su diseño. También se detallan los procesos de implementación y los procedimientos de prueba y sus resultados. Con esta investigación se pretende contribuir con una alternativa de diseño de un monitor cardiaco, que puede utilizarse por un periodo no menor a 30 días. Los resultados demostraron que el equipo desarrollado permite la monitorización cardiaca remota, facilita la movilidad de pacientes y además elimina la necesidad además elimina la necesidad de continuas recargas de energía. ABSTRACTThis paper describes the development and implementation of a heart monitor capable of meeting portability features, easy to use and a prolonged time of operation. The design is divided into two phases. In the first, each stage of the cardiac monitor is implemented prioritizing their individual energy consumption. In the second phase, the stages are integrated to form the cardiac monitor, consisting of a power supply, an interface with the patient, a micro controller, a wireless interface and an application running on a smartphone. To fulfill the two design phases are initially exposed the theoretical foundations and the current development of cardiac monitoring. Subsequently, for each stage, the functional requirements are described and the relevant variables for the design. Also, implementation processes and test procedures and results are detailed. This research is intended to contribute to an alternative design of a heart monitor, which can be used for not less than 30 days period. The results showed that the equipment developed allows remote cardiac monitoring, facilitates the mobility of patients and also eliminates the need for continuous energy refills.

APA, Harvard, Vancouver, ISO, and other styles

7

Patil, Amarjeet D., Sunita A. Patil, Vijay Bhola, Supriya Gokhale Gokhale, and Charu Sudan Sudan. "SUCCINYLCHOLINE CAUSING CARDIAC ARREST." Asian Pacific Journal of Health Sciences 1, no. 2 (April 2014): 69–71. http://dx.doi.org/10.21276/apjhs.2014.1.2.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Prasad, Arun, Sanjeev Kumar, Pradeep Kumar, Manju Kumari, and Rajesh Kumar. "Cardiac Rhabdomyoma in Children." Indian Journal of Trauma and Emergency Pediatrics 10, no. 2 (2018): 49–51. http://dx.doi.org/10.21088/ijtep.2348.9987.10218.3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Geddes, L. A. "Fibrilacion — Defibrilacion cardiaca (Cardiac fibrillation and defibrillation)." Journal of Biomedical Engineering 9, no. 4 (October 1987): 379–81. http://dx.doi.org/10.1016/0141-5425(87)90089-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sotoudehmanesh, Rasoul, and Mohamad Eloubeidi. "Cardia and cardiac tumor: endoscopic ultrasound video." Endoscopy 51, no. 09 (May 9, 2019): E269–269. http://dx.doi.org/10.1055/a-0896-2657.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Álvaro Vázquez Lopez-Cepero, Javier Iborra Escalona, and Vicente Torres-Pedrós. "Dispositivos de asistencia mecánica circulatoria." Revista Electrónica AnestesiaR 10, no. 8 (August 31, 2018): 3. http://dx.doi.org/10.30445/rear.v10i8.630.

Full text

Abstract:

Un dispositivo de asistencia mecánica circulatoria o AMC, es una bomba con capacidad de dar soporte mecánico a un corazón en fallo cardiaco, facilitando el bombeo de la sangre desde las cavidades cardiacas hacia la circulación sistémica. Consideramos asistencia circulatoria a cualquier dispositivo o sistema utilizado para apoyar o sustituir la función cardiaca de forma temporal o, más raramente, permanente. Por norma general nos referimos a las asistencias ventriculares mecánicas y al corazón artificial total. ABSTRACT A mechanical circulatory assist devices (MCADs) , is a pump capable of giving mechanical support to a heart in heart failure, facilitating the pumping of blood from the cardiac cavities to the systemic circulation. We consider circulatory assistance to any device or system used to support or replace cardiac function temporarily or, more rarely, permanently. As a general rule, we refer to mechanical ventricular assist and total artificial heart.

APA, Harvard, Vancouver, ISO, and other styles

12

HASUI, Masahiro, Naoki MUKOUHARA, Morio MARUTANI, Naotsugu OHBAYASHI, Teruo SHRAKI, Shinji UCHIDA, Keiko IHARA, et al. "A case of cardiac lipoma." Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 102, no. 3-4 (1990): 319–23. http://dx.doi.org/10.4044/joma1947.102.3-4_319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Basanets, A. V., T. A. Ostapenko, V. V. Cherkesov, and O. Y. Fartushna. "Sudden cardiac death at workplace." Ukrainian Journal of Occupational Health 2014, no. 2 (June 30, 2014): 13–20. http://dx.doi.org/10.33573/ujoh2014.02.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Jain, Dr Dharmendra, Dr Akash Kumar Pandey, Dr B. K. Das, and Dr Rajniti Prasad. "Cardiac Function in Perinatal Asphyxia." Scholars Journal of Applied Medical Sciences 4, no. 7 (July 2016): 2718–28. http://dx.doi.org/10.21276/sjams.2016.4.7.87.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kumar P R, Nandeesh. "Cardiac Advanced Life Support (CALS)." International Journal of Science and Research (IJSR) 12, no. 9 (September 5, 2023): 1183–87. http://dx.doi.org/10.21275/sr23914154445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cindric Bogdan, Greta. "Cardiac Trauma (cardiac-pericardium tamponade)." Cardiologia Croatica 8, no. 10-11 (October 2, 2013): 331–44. http://dx.doi.org/10.15836/ccar.2013.331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bougouin, Wulfran, and Alain Cariou. "Cardiac Issues in Cardiac Arrest." Seminars in Neurology 37, no. 01 (February 1, 2017): 013–18. http://dx.doi.org/10.1055/s-0036-1593861.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Jagelavicius, Zymantas, Mindaugas Budra, Vytautas Jovaisas, Gintaras Kiskis, Algis Kybartas, Arunas Zilinskas, Irena Liubertiene, Vygantas Gruslys, and Ricardas Janilionis. "CARDIAC SURGERY Penetrating cardiac injuries: 28-year data analysis." Polish Journal of Cardio-Thoracic Surgery 1 (2013): 1–7. http://dx.doi.org/10.5114/kitp.2013.34296.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Tilling, Lindsey. "Hydroxychloroquine and risk of cardiac decompensation." International Journal of Clinical Case Reports and Reviews 4, no. 2 (November 6, 2020): 01–03. http://dx.doi.org/10.31579/2690-4861/053.

Full text

Abstract:

Background Hydroxychloroquine (HCQ) is a 4-aminoquinoline derivative, used in the treatment of malaria and rheumatic diseases. HCQ has also been suggested as a treatment in patients suffering from severe acute respiratory syndrome–coronavirus 2 (SARS–CoV-2). One of the cardiac complications of SARS-CoV-2 is myocarditis and ventricular dysfunction. Case summary We present the case of a 52 year old lady presenting with 2 months history of breathlessness, found to have severely impaired left ventricular function. She had been taking HCQ for 28 months for seronegative inflammatory arthritis. No cause was identified on initial investigation. She was treated with optimal medical therapy, and HCQ was stopped. After 5 months a cardiac MRI scan revealed full remodelling of the ventricle. Discussion This case highlights one of the lesser recognized side effects of HCQ, and the potential for severe cardiac dysfunction. As this drug continues to be investigated and used in the management of SARS-CoV-2 it is important to recognize the potential for cardiac decompensation in patients who are already at increased risk of myocardial dysfunction.

APA, Harvard, Vancouver, ISO, and other styles

20

Singh, Yashbir. "Machine Learning Integration in Cardiac Electrophysiology." Journal of Advanced Research in Dynamical and Control Systems 12, SP4 (March 31, 2020): 942–44. http://dx.doi.org/10.5373/jardcs/v12sp4/20201565.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Shi-Min Yuan, Shi-Min Yuan. "Acute Mesenteric Ischaemia Following Cardiac Operations." 童綜合醫學雜誌 16, no. 1 (June 2022): 001–7. http://dx.doi.org/10.53106/207135922022061601001.

Full text

Abstract:

<p>Acute mesenteric ischaemia (AMI) is an uncommon but sometimes lethal sequel after heart operations. However, no definite diagnostic and therapeutic guidelines have been established so far. It has been reported that AMI occurs on postoperative day six after cardiac operation, with non-occlusive mesenteric ischaemia being the main mechanism leading to AMI. Furthermore, the treatment choices are primarily conservative, including angiography and papaverine infused at 30-60 mg/hour through an angiographic catheter. Others include fluid expansion and antibiotic and anticoagulant treatments. Nevertheless, urgent exploratory laparoscopy or even laparotomy is warranted for patients with peritoneal signs. The surgical principles for treating AMI are bowel resection, embolectomy/thrombectomy and endarterectomy with or without antegrade percutaneous stenting, aiming at restoring blood flow to the superior mesenteric artery. Still, the prognosis is poor, with an overall mortality rate of 71.8%. Therefore, an early suspicion leading to the diagnosis of postoperative AMI is crucial for improving patients’ outcomes.</p> <p> </p>

APA, Harvard, Vancouver, ISO, and other styles

22

Hussain, Md Sadique, and Swati Tyagi. "Cardiac Management in Covid-19 Patients." Pharmaceutics and Pharmacology Research 5, no. 6 (April 26, 2022): 01–03. http://dx.doi.org/10.31579/2693-7247/081.

Full text

Abstract:

Coronavirus disease 2019 (COVID-19) was initially identified in late December 2019 in Wuhan, China. COVID-19 has spreaded swiftly over the planet, becoming a global pandemic affecting over 200 nations and territories, having an extraordinary impact not only on public health but also on social and economic activity.

APA, Harvard, Vancouver, ISO, and other styles

23

Akhila, Chirukuri, Munjam Vaibhav Krishna, and K. Ravinder Reddy. "An Unusual Case of Cardiac Tamponade." International Journal of Science and Research (IJSR) 12, no. 9 (September 5, 2023): 1181–82. http://dx.doi.org/10.21275/sr23913081350.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Toyoshima, Osamu, Toshihiro Nishizawa, Kosuke Sakitani, Tadahiro Yamakawa, Hidenobu Watanabe, Shuntaro Yoshida, Yousuke Nakai, et al. "Nodularity-like appearance in the cardia: novel endoscopic findings for Helicobacter pylori infection." Endoscopy International Open 08, no. 06 (May 25, 2020): E770—E774. http://dx.doi.org/10.1055/a-1136-9890.

Full text

Abstract:

Abstract Background and study aims Helicobacter pylori-associated nodular gastritis, which is associated with follicular lymphoid hyperplasia, is mainly recognized in the antrum. However, we have also observed nodularity-like appearance in the cardia. This study aimed to investigate the clinical signiﬁcance of cardiac nodularity-like appearance in H. pylori-associated gastritis. Patients and methods Patients who underwent esophagogastroduodenoscopy and were evaluated for H. pylori infection for the ﬁrst time were enrolled. A nodularity-like appearance in the cardia was defined as a miliary nodular appearance or scattered appearances of small circular whitish coloration. H. pylori infection was diagnosed according to serum anti-H. pylori antibody and the urea breath test or histology. Accuracy of the H. pylori infection diagnoses based on nodularity-like appearance were assessed. Results Among 265 patients, 42 patients (15.8 %) were diagnosed as positive for H. pylori. Cardiac nodularity-like appearance and antral nodularity were recognized in 25 and 15 patients, respectively. In accuracy of predicting H. pylori by cardiac nodularity-like appearance, specificity was 0.996, sensitivity was 0.571, positive predictive value was 0.960, negative predictive value was 0.925, and accuracy was 0.928. The sensitivity of cardiac nodularity-like appearance was significantly higher than that of antral nodularity (P = 0.0284). Conclusions Cardiac nodularity-like appearance had a high accuracy rate for H. pylori infection diagnosis. Cardiac nodularity-like appearance was found more frequently than antral nodularity.

APA, Harvard, Vancouver, ISO, and other styles

25

M Nair, Mighila. "Effectiveness of Exercise Based Cardiac Rehabilitation on Selected Cardiac Parameters among Postoperated CABG Patient in Selected Hospital." Indian Journal of Surgical Nursing 9, no. 1 (April 1, 2020): 31–36. http://dx.doi.org/10.21088/ijsn.2277.467x.9120.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Murphy, Emily C., Lesley Cottrell, Alyson Ward, Valerie Minor, Eloise Elliott, and William A. Neal. "CARDIAC." Medicine & Science in Sports & Exercise 39, Supplement (May 2007): S198. http://dx.doi.org/10.1249/01.mss.0000273739.36423.e1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kampa, Courtney. "Cardiac." New England Review 33, no. 4 (2013): 102. http://dx.doi.org/10.1353/ner.2013.0001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sherif, Khaled, Carlos Ceron Castro, Christian Avalos, Humberto Mochizuki Tamayo, Ruben Abreu, and Y. Wady Aude. "CARDIAC HAMARTOMA: A RARE CARDIAC TUMOR." Journal of the American College of Cardiology 77, no. 18 (May 2021): 2597. http://dx.doi.org/10.1016/s0735-1097(21)03952-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Kent, Elizabeth. "Chronic Cardiac Disease Chronic Cardiac Disease." Nursing Standard 17, no. 22 (February 12, 2003): 28. http://dx.doi.org/10.7748/ns2003.02.17.22.28.b331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hopper, Ingrid. "Cardiac effects of non-cardiac drugs." Australian Prescriber 34, no. 2 (April 1, 2011): 52–54. http://dx.doi.org/10.18773/austprescr.2011.030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Udzik, Jakub, Sandra Sienkiewicz, Andrzej Biskupski, Aleksandra Szylińska, Zuzanna Kowalska, and Patrick Biskupski. "Cardiac Complications Following Cardiac Surgery Procedures." Journal of Clinical Medicine 9, no. 10 (October 18, 2020): 3347. http://dx.doi.org/10.3390/jcm9103347.

Full text

Abstract:

Background: Elderly patients and those with multiple concomitant disorders are nowadays qualified for cardiac surgery procedures, which is related to higher incidence of the postoperative complications. Aim: The aim of this study was a retrospective analysis of the perioperative factors potentially contributing to occurrence of cardiac incidents after cardiac surgery procedures. Methods: Data of 552 patients of the cardiac surgery clinic were collected and analyzed. Data concerning medical history, previous treatment, laboratory results, additional tests results, operation and hospitalization period were examined. Results: In the study population of 552 patients, cardiac complications were observed in 49.5% of them. Among cardiac complications, the most frequent were supraventricular tachycardia (30.1%) and atrial fibrillation (27.4%). Postoperative bradycardia occurred in 5.25% patients, half of whom required temporary cardiac pacing. Conclusions: The risk of incidence of cardiac complications after cardiac surgery procedures depends mostly on patient’s age, EuroSCORE Logistic (ESL) score, left ventricular ejection fraction, myocardial hypertrophy, presence of paroxysmal AF and coincidence of nephrological complications. The necessity of performing more than one heart defibrillation after removing aortic cross-clamp favors early postoperative bradycardia. Considering the outcomes of this study, continuing reperfusion at least until 1/3 of the aortic cross-clamp time brings no additional benefits to the patients.

APA, Harvard, Vancouver, ISO, and other styles

32

CARROLL, P. V., V. MARKIDES, and R. M. LEACH. "Localised cardiac tamponade following cardiac surgery." Clinical Intensive Care 7, no. 1 (February 1996): 42–44. http://dx.doi.org/10.3109/tcic.7.1.42.44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Kass, David A. "Cardiac Resynchronization Therapy and Cardiac Reserve." Circulation 113, no. 7 (February 21, 2006): 923–25. http://dx.doi.org/10.1161/circulationaha.105.604603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Lindsey, Jennifer, and Richard B. Stacey. "Cardiac magnetic resonance in cardiac angiosarcoma." Echocardiography 34, no. 7 (June 29, 2017): 1077–81. http://dx.doi.org/10.1111/echo.13598.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Yamasaki, Yuzo, Mayumi Yoshikawa, Koji Sagiyama, and Takeshi Kamitani. "Active Cardiac Sarcoidosis Imitating Cardiac Metastases." Radiology: Cardiothoracic Imaging 2, no. 6 (December 1, 2020): e200310. http://dx.doi.org/10.1148/ryct.2020200310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

López-Herce, Jesús, and Jimena del Castillo. "Cardiac Arrest in Pediatric Cardiac ICUs." Pediatric Critical Care Medicine 18, no. 10 (October 2017): 989–90. http://dx.doi.org/10.1097/pcc.0000000000001290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Abbas, A., K. A. G. Garfath-Cox, I. W. Brown, J. S. Shambrook, C. R. Peebles, and S. P. Harden. "Cardiac MR assessment of cardiac myxomas." British Journal of Radiology 88, no. 1045 (January 2015): 20140599. http://dx.doi.org/10.1259/bjr.20140599.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Fukuda, Keiichi, Hideaki Kanazawa, Yoshiyasu Aizawa, Jeffrey L. Ardell, and Kalyanam Shivkumar. "Cardiac Innervation and Sudden Cardiac Death." Circulation Research 116, no. 12 (June 5, 2015): 2005–19. http://dx.doi.org/10.1161/circresaha.116.304679.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Foëx, Bernard A., and Emyr W. Benbow. "Standby…cardiac arrest…standby…cardiac arrest*." Critical Care Medicine 34, no. 2 (February 2006): 554–55. http://dx.doi.org/10.1097/01.ccm.0000196092.72359.21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Rokitansky, A., and E. Wolner. "Cardiac Support and Mechanical Cardiac Replacement." International Journal of Artificial Organs 14, no. 7 (July 1991): 387–92. http://dx.doi.org/10.1177/039139889101400701.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Pennec, P. Y., and J. J. Blanc. "Cardiac lymphangioma: a benign cardiac tumour." European Heart Journal 27, no. 24 (April 7, 2006): 2913. http://dx.doi.org/10.1093/eurheartj/ehl028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Sommers, Marilyn Sawyer. "Cardiac Tamponade After Nonpenetrating Cardiac Trauma." Dimensions of Critical Care Nursing 5, no. 4 (July 1986): 206–15. http://dx.doi.org/10.1097/00003465-198607000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Eillis, Myra F. "Low Cardiac Output Following Cardiac Surgery." Dimensions of Critical Care Nursing 16, no. 1 (January 1997): 48–55. http://dx.doi.org/10.1097/00003465-199701000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Engle, Mary Allen. "Cardiac Surgery Without Preoperative Cardiac Catheterization." Pediatric Annals 16, no. 8 (August 1, 1987): 623–28. http://dx.doi.org/10.3928/0090-4481-19870801-07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

RADEMAKER, Miriam T., and A. Mark RICHARDS. "Cardiac natriuretic peptides for cardiac health." Clinical Science 108, no. 1 (December 15, 2004): 23–36. http://dx.doi.org/10.1042/cs20040253.

Full text

Abstract:

The cardiac natriuretic peptides, ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide), are secreted by the heart in proportion to cardiac transmural pressures. They possess a wide range of effects in multiple tissues facilitating overall pressure/volume homoeostasis. The close relationship between plasma concentrations of these peptides and ‘cardiac load’ has led to their use as biomarkers of cardiac health with diagnostic and prognostic applications in a variety of disorders affecting the cardiovascular system. BNP and its N-terminal fragment (NT-BNP) are especially sensitive indicators of cardiac dysfunction and remodelling, and correlate strongly with severity. Given that cardiac ischaemia is also an important trigger for the release of these ventricular peptides, they may likewise play a role in the detection of coronary artery disease. Measurement of BNP/NT-BNP shows particular promise as a ‘rule out’ test for suspected cases of HF (heart failure) in both emergency care and outpatient settings, and may assist in identifying individuals with asymptomatic ventricular impairment who will benefit from therapy preventing progression to overt HF. The BNP peptides also predict subsequent haemodynamic deterioration and adverse events in cardiovascular disease, and can therefore be used to monitor those at high risk and act as a guide to optimization of treatment. The favourable biological properties of the natriuretic peptides have also led to their use as therapeutic agents.

APA, Harvard, Vancouver, ISO, and other styles

46

Mohsen, A., and K. El-Kersh. "Non-cardiac causes of cardiac tamponade." Case Reports 2013, sep13 2 (September 13, 2013): bcr2013010170. http://dx.doi.org/10.1136/bcr-2013-010170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Florea, Viorel G., Michael Y. Henein, Mathias Rauchhaus, Veronika Koloczek, Rakesh Sharma, Wolfram Doehner, Philip A. Poole-Wilson, Andrew J. S. Coats, and Stefan D. Anker. "The cardiac component of cardiac cachexia." American Heart Journal 144, no. 1 (July 2002): 45–50. http://dx.doi.org/10.1067/mhj.2002.123314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Anthi, Anastasia, George E. Tzelepis, Peter Alivizatos, Alkis Michails, George M. Palatianos, and Stephanos Geroulanos. "Unexpected Cardiac Arrest After Cardiac Surgery." Chest 113, no. 1 (January 1998): 15–19. http://dx.doi.org/10.1378/chest.113.1.15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Kron, Irving L., John A. Kern, George A. Beller, James Bergin, Steven M. Fiser, James J. Gangemi, John A. McPherson, and Eric R. Powers. "Cardiac screening before non-cardiac operations." Current Problems in Surgery 37, no. 6 (June 2000): 385–454. http://dx.doi.org/10.1016/s0011-3840(00)80008-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Reddy, V. Seenu, Ho H. Phan, Richard N. Pierson, Davis C. Drinkwater, Paul A. Chang, Stacy F. Davis, and Walter H. Merrill. "Late cardiac reoperation after cardiac transplantation." Annals of Thoracic Surgery 73, no. 2 (February 2002): 534–37. http://dx.doi.org/10.1016/s0003-4975(01)03337-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!